Related Experiment Video
Updated: Oct 23, 2025
12:21
Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells
Published on: March 3, 2016
10.6K
Human embryonic stem cell-derived melanocytes exhibit limited immunogenicity
Jinqi Wang1, Xuanhao Zeng1, Yating Liu1
1Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Biochemical and Biophysical Research Communications
|August 20, 2021
Summary
Embryonic stem cell-derived melanocytes show low immunogenicity, making them promising for vitiligo regenerative medicine. These cells are suitable for transplantation, reducing immune rejection concerns in treating skin conditions.
Area of Science:
- Regenerative Medicine
- Immunology
- Dermatology
Background:
- Surgical interventions for vitiligo can cause grafting injuries.
- Allogeneic transplantation of embryonic stem cell (ESC) derivatives raises concerns about immune rejection.
- Developing safer cell-based therapies for vitiligo is crucial.
Purpose of the Study:
- To investigate the immunogenicity of ESC-derived melanocytes (ES-MC).
- To assess the potential of ES-MC for regenerative medicine applications, specifically in vitiligo treatment.
Main Methods:
- Established a co-culture system of ES-MC and allogeneic peripheral blood mononuclear cells (PBMC).
- Analyzed the expression of immune-related molecules on ES-MC.
- Evaluated the capacity of ES-MC to stimulate allogeneic lymphocytes in vitro.
Main Results:
- ES-MC exhibited low expression of immune-related molecules.
- ES-MC demonstrated limited capability to stimulate allogeneic lymphocytes in vitro.
- ES-MC showed similar immunogenic profiles to human primary melanocytes.
Conclusions:
- ESC-derived melanocytes possess limited immunogenicity.
- ES-MC represent a viable option for transplantation in regenerative medicine.
- These findings support the application of ES-MC for treating vitiligo and reducing immune rejection.
Related Concept Videos
00:57Embryonic Stem Cells
4.1K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.1K
01:06Induced Pluripotent Stem Cells
4.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.7K
01:17Stem Cell Culture
5.7K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.7K